News Conference News CX Symposium 2025 Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI L.A. McKeown April 30, 2025
News Conference News CX Symposium 2025 Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK L.A. McKeown April 24, 2025
News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices L.A. McKeown April 23, 2025
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Daily News Platelet Hyperreactivity Score May Improve CVD Risk Detection L.A. McKeown August 23, 2024
News Daily News BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI L.A. McKeown April 24, 2024
News Daily News Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail L.A. McKeown April 22, 2021
News Conference News TCT 2020 IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs L.A. McKeown October 18, 2020
News Conference News VEITH 2019 More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD L.A. McKeown November 22, 2019
News Features Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients? Caitlin E. Cox May 01, 2019
News Conference News ISET 2019 Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched Caitlin E. Cox January 28, 2019
News Daily News New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration L.A. McKeown December 18, 2018